Photo=KMDB Korean Auteur Park Chan-wook to Lead Cannes Jury, Marking Industry Milestone Park Chan-wook, a towering figure of South Korean cinema, has been named jury president of the 79th Cannes Film Festival, marking a first for a Korean filmmaker and underscoring his stature as one of the defining auteurs of contemporary global film.  The appointment places Park at the helm

Photo=Coupang Coupang Inc. reported record annual results on February 27, posting $34.53 billion in revenue for 2025, up 14% from $30.27 billion a year earlier, according to a filing with the U.S. Securities and Exchange Commission. Annual operating income rose 8% to $473 million, marking the third consecutive year above $400 million. Net income climbed to $214 million, more than

(Photo=CJ CheilJedang) The idea that beauty can be maintained from within—through what consumers eat and drink—has moved from niche wellness circles into the U.S. mainstream. Capsules, powders and functional beverages promising skin benefits have proliferated, but so has skepticism. Retailers and regulators are increasingly demanding hard evidence to support claims long driven by marketing. That shift is reshaping competition in

Photo=Motionelements South Korea’s startup formation is shrinking overall, but beneath the headline decline a structural shift is taking shape—one that is steadily tilting the country’s entrepreneurial landscape toward technology-driven sectors. Data released by the Ministry of SMEs and Startups show that 1.14 million new businesses were established in 2025, down 4.0% from a year earlier and marking the fifth consecutive

(Photo=Hanmi Pharmceutical) A takeover agreement between Hanmi Pharmaceutical and Aptose Biosciences is drawing attention in U.S. biotech circles, as a mid-sized South Korean drugmaker moves to secure a direct operating base in North America’s cancer drug market. Hanmi Pharmaceutical, founded in 1973 and one of South Korea’s leading research-driven pharmaceutical companies, has built its global presence largely through licensing deals